… — or love someone who is — a treatment that could slow symptoms or prevent them from occurring offers real hope. These … Successful disease-modifying therapies would change how we treat Parkinson’s. Yet while these therapies are … for people in advanced stages. For these reasons, we remain committed to pushing research further so that future …

…              We will test the hypothesis that whole blood DNA methylation in Parkinson’s disease (PD) will be altered at specific sites compared to either healthy controls or to Alzheimer’s disease (AD). …

… disorder that does not only affect movement but also the autonomic nervous system. Since most people start developing … of the disease and optimize treatment. We have previously shown that we can assess autonomic nerve fiber function with … and three years after the beginning of the study. We will compare goose bump responses with measures of other …

… Test1.pdf …

… Study Rationale:  To slow the progression of Parkinson disease (PD), we need to understand how, where and why the illness starts. It is estimated that … fluid specimens from people with PD who have been carefully tested for their sense of smell over several years to …

… Home Page Cancel Register for Webinar Alpha-synuclein: Stopping the Sticky Protein behind Parkinson's First Name   … had PD I am a researcher, clinician or work with the PD community Other   Diagnosis Date ${selected} Jan Feb Mar Apr … alpha-synuclein and Lewy bodies. Discuss therapies that target alpha-synuclein in development for potential …